A new antiretroviral (ARV) pricing agreement reached by the South African government, international organisations and agencies will ensure that more people will have access to treatment, while saving South Africa nearly R12-billion over the next six years. A statement released by the Department of Health on Friday revealed that the single-pill HIV treatment regimen containing dolutegravir (DTG) will be available to low and middle-income countries at a price of $75 per person, a year.
Source: www.engineeringnews.co.za
Lower ARV price to benefit S Africa, increase recipient numbers
Made with by iNCO Creative.